Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-002556
Filing Date
2017-01-06
Accepted
2017-01-06 13:04:06
Documents
2
Period of Report
2017-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13651
2 POA DOCUMENT poa.txt EX-24.4_693724 4765
  Complete submission text file 0001209191-17-002556.txt   19784
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DR. SUITE 150 IRVING TX 75063
Business Address
Bass James Edward (Reporting) CIK: 0001662321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 17513592